Viridian stock jumps on data for lead drug (NASDAQ:VRDN)

magicmine/iStock via Getty Images Viridian Therapeutics (NASDAQ:VRDN) on Tuesday announced topline results from its THRIVE Phase 3 clinical trial designed to assess its lead candidate veligrotug (VRDN-001) in patients with active thyroid eye disease (TED). Based on 15-week data, the company said that the 113-patient trial met the primary endpoint after five infusions, indicating a … Read more

Venezuela’s Maduro needs to release election data, White House says By Reuters

By Gabriella Borter WASHINGTON (Reuters) – Venezuelan President Nicolas Maduro needs to release election data from July’s disputed election to address global concerns about its validity, White House national security spokesman John Kirby (NYSE:) said on Monday. Opposition candidate Edmundo Gonzalez has gone to Spain to seek asylum in the wake of the election, Venezuelan … Read more

France asks EU to let it delay submitting budget deficit plan, La Tribune reports By Reuters

PARIS (Reuters) – France has asked the European Commission to extend beyond Sept. 20 its deadline for submitting a plan to reduce its public deficit to ensure coherence with Paris’ 2025 draft budget, La Tribune du Dimanche said on Sunday, citing the Finance Ministry. France could see its budget deficit spiral unexpectedly higher this year … Read more

Stellantis to recall 1.46M vehicles in the U.S. (NYSE:STLA)

jetcityimage/iStock Editorial via Getty Images Update: 2.34 PM EST: Includes Stellantis’ comments about global recall Chrysler owner Stellantis (NYSE:STLA) on Saturday announced plans to recall 1.46M vehicles worldwide, including nearly 1.2M vehicles in the U.S., due to a software malfunction in the anti-lock brake system that can increase the risk of a crash. The recall … Read more